PROS1 and COVID-19: Although the Moderna COVID-19 vaccine (mRNA 1273) could be effective against the N501Y mutation, additional mutations in the South African variant (501Y.V2), Indian and Australian variants are likely to influence its S protein affinity to the host receptor and evading neutralization.